We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7-36) Levels in Patients with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia.
- Authors
Suzuki, Tatsuya; Oba, Kenzo; Igari, Yoshimasa; Matsumura, Noriaki; Watanabe, Kentaro; Futami-Suda, Shoko; Yasuoka, Hiroko; Ouchi, Motoshi; Suzuki, Kazunari; Kigawa, Yoshiaki; Nakano, Hiroshi
- Abstract
Background: Colestimide has been reported to lower blood glucose levels in patients with type 2 diabetes complicated by hypercholesterolemia. Aim: To examine the mechanism by which colestimide decreases plasma glucose levels in the above patients. Methods: A total of 16 inpatients with type 2 diabetes complicated by hypercholesterolemia received colestimide for 1 week after their plasma glucose levels stabilized. We measured plasma glucose, serum immunoreactive insulin (IRI), serum lipid, plasma glucagon, and plasma glucagon-like peptide-1 (GLP-1) levels. These variables at baseline and 1 week of colestimide administration were compared. Results: Preprandial plasma glucose levels (baseline: 132 ± 33 mg/dL vs. completion: 118 ± 43 mg/dL, P=0.073) tended to decrease after colestimide administration, while 1-hr postprandial plasma glucose levels (baseline: 208 ± 49 mg/dL vs. completion: 166 ± 30 mg/d.L, P<0.001) and 2-hr postprandial plasma glucose levels (baseline: 209 ± 56 mg/dL vs. completion: 178 ± 39 mg/d.L, P=0.015) decreased significantly at 1 week of colestimide administration. The 2-hr postprandial plasma GLP-1 level was significantly (P=0.015) higher at 1 week of coleslimide administration as compared with the baseline level, while there were no significant changes in preprandial and 1-hr postprandial plasma GLP-1 levels. Conclusions: The GLP-l-increasing activity of colestimide may explain, at least in part, the mechanism of its blood glucose-lowering activity in patients with type 2 diabetes complicated by hypercholesterolemia.
- Subjects
BLOOD sugar; SUGAR in the body; TYPE 2 diabetes; HYPERCHOLESTEREMIA; BLOOD lipids; INSULIN
- Publication
Journal of Nippon Medical School, 2007, Vol 74, Issue 5, p338
- ISSN
1345-4676
- Publication type
Article
- DOI
10.1272/jnms.74.338